Book Value per Share: BiomX Inc. (PHGE)

The historical book value per share chart demonstrates the equity dynamics of BiomX Inc. (PHGE), where the 3.71 mark serves as a key metric. The company's revenues are based on the development of phage preparations for the treatment of acne and intestinal inflammation. However, strict FDA oversight and patent protection create significant market barriers, while high clinical costs result in a liquidity deficit.

Assessing the liquidation cushion via book value per share allows for the determination of the actual amount of equity attributable to a single security in the event of a hypothetical business closure. By analyzing the historical book value chart for BiomX Inc. (PHGE), an investor can compare the level of asset protection against the costs of scaling phage therapies and developing B2B partnerships to avoid the risk of inefficient capital allocation.